Home › Funds › ESSEX INVESTMENT MANAGEMENT CO LLC › SOPH

ESSEX INVESTMENT MANAGEMENT CO LLC position in SOPH

SOPHIA GENETICS SA · Technology

ESSEX INVESTMENT MANAGEMENT CO LLC reported holding 643,129 shares of SOPH (SOPHIA GENETICS SA) in its Q3 2026 13F filing — a position valued at US$5.4M, representing 0.80% of its reported portfolio and ranking #44 among its reported holdings. ESSEX INVESTMENT MANAGEMENT CO LLC has disclosed SOPH holdings in 6 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)643.13K sh
Reported value held$5.39M
Portfolio Weight0.80%
First reportedQ4 2023
Last changeReduce
Updated2026-10-21

Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR

How ESSEX INVESTMENT MANAGEMENT CO LLC's SOPH position evolved

ESSEX INVESTMENT MANAGEMENT CO LLC first disclosed a stake in SOPH in Q4 2023 at 123,901 shares (US$584K). The position peaked in Q3 2026 at 643,129 shares, worth US$5.4M. Across 6 filings, ESSEX INVESTMENT MANAGEMENT CO LLC increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 643,129 shares valued at US$5.4M — a reduction of -20,299 shares quarter over quarter.. Notable position changes include a 112% increase in Q1 2024 (shares fell 7% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 123.90K $583.57K New
Q1 2024 262.83K $1.30M Add
Q2 2024 305.34K $1.40M Add
Q1 2026 692.81K $3.43M New
Q2 2026 663.43K $3.83M Reduce
Q3 2026 643.13K $5.39M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SOPH and 13F data

SOPH (SOPHIA GENETICS SA) is a Technology company. 60 other funds we track also report a position in SOPH — the largest reported positions include GENERATION INVESTMENT MANAGEMENT LLP (US$39.2M), AIGH Capital Management LLC (US$22.8M), AKRE CAPITAL MANAGEMENT LLC (US$21.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SOPH

All SOPH fund holders →

FAQ

How long has ESSEX INVESTMENT MANAGEMENT CO LLC held SOPH?

ESSEX INVESTMENT MANAGEMENT CO LLC has disclosed SOPH holdings in 6 of the last 12 reported quarters, going back to Q4 2023.

What is ESSEX INVESTMENT MANAGEMENT CO LLC's current position in SOPH?

As of Q3 2026, ESSEX INVESTMENT MANAGEMENT CO LLC holds 643.13K shares of SOPH (SOPHIA GENETICS SA), valued at $5.39M, representing 0.80% of its reported portfolio and ranking #44.

Has ESSEX INVESTMENT MANAGEMENT CO LLC been buying or selling SOPH?

In the latest 13F filing (Q3 2026), ESSEX INVESTMENT MANAGEMENT CO LLC reduced its position in SOPH. The position peaked in Q3 2026 at 643.13K shares.

Which other funds hold SOPH?

Other major institutional holders of SOPH include GENERATION INVESTMENT MANAGEMENT LLP, AIGH Capital Management LLC, AKRE CAPITAL MANAGEMENT LLC, among 60 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.